These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2827156)

  • 21. Mapping antibody binding sites on cytochrome c with synthetic peptides: are results representative of the antigenic structure of proteins?
    Schwab C; Twardek A; Lo TP; Brayer GD; Bosshard HR
    Protein Sci; 1993 Feb; 2(2):175-82. PubMed ID: 7680266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-alpha expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L).
    Arroyo CM; Burman DL; Kahler DW; Nelson MR; Corun CM; Guzman JJ; Smith MA; Purcell ED; Hackley BE; Soni SD; Broomfield CA
    Cell Biol Toxicol; 2004 Nov; 20(6):345-59. PubMed ID: 15868479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion.
    Pascual DW; Bost KL
    Pept Res; 1989; 2(3):207-12. PubMed ID: 2485208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Structural mechanism studies of hTNF alpha mutants in position 30 and 42 amino acid].
    Hu F; Dong SZ; Liu LD; He SQ; Zhao SD; Li QH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):144-8. PubMed ID: 12905791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
    Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
    Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and functional domains in human tumour necrosis factors.
    Goh CR; Porter AG
    Protein Eng; 1991 Apr; 4(4):385-9. PubMed ID: 1715560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
    Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
    J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional requirement of the two TNF receptors for induction of apoptosis in PC60 cells and the role of mitochondria in TNF-induced cytotoxicity.
    Vandenabeele P; Goossens V; Beyaert R; Declercq W; Grooten J; Vanhaesebroeck B; Van de Craen M; Vercammen D; Depuydt B; Denecker G
    Circ Shock; 1994 Dec; 44(4):196-200. PubMed ID: 7628061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling.
    Zhang W; Feng J; Li Y; Guo N; Shen B
    Mol Immunol; 2005 Aug; 42(12):1445-51. PubMed ID: 15950738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum.
    McVittie LD; Ariano MA; Sibley DR
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1441-5. PubMed ID: 1825357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of synthetic human tumor necrosis factor is toxic to Escherichia coli.
    Binepal G; Ranjan RK; Rajagopal K
    Gene; 2012 Feb; 493(1):155-60. PubMed ID: 22143035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha.
    Gase K; Korobko VG; Wisniewski HG; Le J; Dobrynin VN; Filippov SA; Gutsche W; Maksimova YN; Schlott B; Shingarova LN
    Immunology; 1990 Nov; 71(3):368-71. PubMed ID: 2269475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human chorionic gonadotropin-specific antiserum against synthetic peptide analogs to the carboxyl-terminal peptide of its beta-subunit.
    Matsuura S; Ohashi M; Chen HC; Hodgen GD
    Endocrinology; 1979 Feb; 104(2):396-401. PubMed ID: 446368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of human TNF-alpha action by flecainide acetate, an antiarrhythmic drug.
    Nojima S; Kobuchi H; Saibara T; Yasuda T; Utsumi K
    Physiol Chem Phys Med NMR; 1995; 27(2):77-89. PubMed ID: 7568419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6.
    Brouckaert P; Libert C; Everaerdt B; Takahashi N; Cauwels A; Fiers W
    Immunobiology; 1993 Apr; 187(3-5):317-29. PubMed ID: 8392490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.